Zástupcovia spoločnosti Glycanostics na stretnutí s predsedníčkou Európskej komisie, Ursulou von der Leyenovou

V pondelok 21. júna mala naša CEO Eva Kováčová (na obrázku vpravo) a náš CSO Ján Tkáč (vľavo) veľkú česť predstaviť spoločnosť Glycanostics za prítomnosti predsedníčky Európskej komisie Ursuly von der Leyenovej, premiéra Eduarda Hegera a podpredsedu Európskej komisie Maroša Šefčoviča. Ako jedna zo siedmich inovatívnych spoločností sme prezentovali naše mimoriadne presné, neinvazívne diagnostické testy na rakovinu […]

Dôležitý krok pre spoločnosť Glycanostics v spolupráci s Crowdberry Investment Management (CBIM)

Glycanostics a Crowdberry Investment Management podnikli dôležitý krok k dosiahnutiu vízie našej spoločnosti. V piatok 7. mája 2021 sme podpísali investičnú dohodu, na základe ktorej získa Glycanostics kľúčové finančné zdroje vo výške 310 000 eur. Investícia spoločnosti Crowdberry zásadným spôsobom urýchli našu snahu o záchranu mnohých životov po celom svete vďaka neinvazívnemu diagnostickému testu na rakovinu prostaty. Investičná […]

A HIGHLY-PRESTIGIOUS AWARD FOR A GLYCANOSTICS CO-FOUNDER

This year, a well-established IT company from Slovakia ESET launched a prestigious ESET Science Award for exceptional scientists to increase the popularity of excellent scientists. Among all the scientists nominated, the winner of the main category and recipient of 100 000 € became Jan Tkac, CSO and co-founder of the Glycanostics company. All finalists were […]

INTERNATIONAL PATENT APPLICATION NO. PCT/EP2019/057386

On 3rdOctober 2019, PCT application titled “Means and methods for glycoprofiling of aprotein” (applicant Glycanostics, inventors Tomas Bertok and Jan Tkac) waspublished under publication number WO 2019/185515. This patent applicationcovers the main principles and company´s IP used during the diagnostic assaydevelopment. Patent abstract: Thepresent invention provides magnetic carriers, anti-glycoprotein antibodies, theantigen binding portions thereof, one or […]

GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS

With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best Health-Tech Startup and Best SocialImpact Startup. As a winner in the latter category, Glycanostics became a partof this year´s Accace life accelerator (by Accace company), which ended up withan investor […]

GLYCANOSTICS WINS HORIZON 2020 GRANT

After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics‘ next submission, to the Horizon 2020 Programme, won a € 50 000 grant. The Horizon 2020 Programme for Research and Innovation 2014-2020 aims to support excellent science, industrial leadership and social impact startups. Its main goal is to ensure that European countries […]

GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”

The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme for Research and Innovation 2014-2020, and received the highest scores for its proposal in the extremely competitive evaluation process. The European Commission has a rigorous evaluation system—with a panel of […]

GLYCANOSTICS WINS TOP-6 BEST STARTUPS IN CENTRAL EUROPE

The FutureNow startup competition, also known as the Startup Awards, is akin to the Oscars for the best startups with global potential. This year marked the eighth and largest occurrence of the competition, open to participants from 17 European countries, with 128 registered start-ups.  Glycanostics was chosen as a finalist in the Grand Finale with […]

GLYCANOSTICS SUCCESFULLY FINISHED HORIZON 2020 SME INSTRUMENT 1 GRANT

In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency. Further information are in the Publishable summary, which can be downloaded from this link.